author-photo

Sanjeewa S. Wickremasinghe

University of Melbourne

73

Papers

1482

Citations

Citation Trend

Filter By

Papers (51) Sort By

Journal Conference Others

Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.

2021 British Journal of Ophthalmology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 Study of an Intravitreal Axitinib Hydrogel-based Implant for the Treatment of Neovascular Age-Related Macular Degeneration (nAMD)

2021 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Diabetic retinopathy progression 6 months post cataract surgery with intravitreous bevacizumab vs triamc1inolone: A secondary analysis of the DiMECAT trial.

2020 Clinical and Experimental Ophthalmology
Show All
- Source
- Cite
- Save
Citations (1)
Intravitreal injection does not change anterior chamber morphology on anterior segment optical coherence tomography.

2020 Clinical and Experimental Ophthalmology
Show All
- Source
- Cite
- Save
Citations (0)
Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration

2019 Ophthalmology
Show All
- Source
- Cite
- Save
Citations (5)
Dexamethasone implant for the treatment of persistent diabetic macular oedema despite long‐term treatment with bevacizumab

2019 Clinical and Experimental Ophthalmology
Show All
- Source
- Cite
- Save
Citations (1)
Central retinal artery occlusion showing features of paracentral acute middle maculopathy following uncomplicated pterygium surgery: Letter to the Editor

2019 Clinical and Experimental Ophthalmology
Show All
- Source
- Cite
- Save
Citations (6)
Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results

2019 British Journal of Ophthalmology
Show All
- Source
- Cite
- Save
Citations (7)
Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report

2019 Ophthalmology Retina
Show All
- Source
- Cite
- Save
Citations (15)
The DiMECat Trial: A Prospective, Randomised Clinical Trial Of Intravitreous Bevacizumab vs. Triamcinolone In Patients With Diabetic Macular Oedema At The Time Of Cataract Surgery – 6 Month Results

2018 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (1)